[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
India’s Central Drugs Standard Control Organization (CDSCO) has completed its sampling of domestic drug manufacturers (see IPQ August 15, 2014) and is turning its attention to ingredients entering the country. PharmaBiz reports that CDSCO and the National Institute of Biologicals (NIB) are working together on the program. The first major step was the reallocation of CDSCO assistant drugs controllers from the regulator’s head office to its operations at 12 ports where the sampling will take place.
[/membership]
INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue
